Halozyme Therapeutics
HALO
#2398
Rank
โ‚ฌ5.88 B
Marketcap
46,23ย โ‚ฌ
Share price
1.19%
Change (1 day)
29.81%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ1.58 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ1.58 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ1.49 B-4.26%
2022-12-31โ‚ฌ1.55 B94.49%
2021-12-31โ‚ฌ0.80 B129.81%
2020-12-31โ‚ฌ0.34 B-17.61%
2019-12-31โ‚ฌ0.42 B153.01%
2018-12-31โ‚ฌ0.16 B-35.58%
2017-12-31โ‚ฌ0.25 B-7.09%
2016-12-31โ‚ฌ0.27 B120.19%
2015-12-31โ‚ฌ0.12 B23.87%
2014-12-31โ‚ฌ0.10 B16.2%
2013-12-31โ‚ฌ88.18 M35.83%
2012-12-31โ‚ฌ64.92 M53.68%
2011-12-31โ‚ฌ42.24 M-20.86%
2010-12-31โ‚ฌ53.37 M8.86%
2009-12-31โ‚ฌ49.03 M12.03%
2008-12-31โ‚ฌ43.76 M39.85%
2007-12-31โ‚ฌ31.29 M79.45%
2006-12-31โ‚ฌ17.43 M796.84%
2005-12-31โ‚ฌ1.94 M67%
2004-12-31โ‚ฌ1.16 M436.09%
2003-12-31โ‚ฌ0.21 M-62.79%
2002-12-31โ‚ฌ0.58 M15572.49%
2001-12-31โ‚ฌ0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.64 B-59.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ58.29 B 3,580.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.81 B 1,024.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ120.72 B 7,521.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ57.87 B 3,553.55%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ102.85 B 6,392.95%๐Ÿ‡บ๐Ÿ‡ธ USA